Legend Biotech Files 2025 Annual Meeting Voting Results
Ticker: LEGN · Form: 6-K · Filed: Jun 12, 2025 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, voting-results, sec-filing
TL;DR
Legend Biotech filed its 2025 AGM voting results; standard procedure, no surprises.
AI Summary
Legend Biotech Corporation held its 2025 Annual General Meeting of Shareholders on June 12, 2025. The voting results from this meeting have been filed with the SEC as Exhibit 99.1 to this Form 6-K. These results will be incorporated into the company's existing registration statements on Form F-3 and Form S-8.
Why It Matters
This filing provides transparency on shareholder voting outcomes, which can influence corporate governance and future strategic decisions.
Risk Assessment
Risk Level: low — The filing reports on routine annual meeting voting results, which typically do not introduce new material risks.
Key Players & Entities
- Legend Biotech Corporation (company) — Registrant
- June 12, 2025 (date) — Date of Annual General Meeting
- Exhibit 99.1 (document) — Attached voting results
- Form F-3 (document) — Registration statement
- Form S-8 (document) — Registration statement
FAQ
What was the primary purpose of this Form 6-K filing?
The primary purpose was to report the voting results from Legend Biotech Corporation's 2025 Annual General Meeting of Shareholders held on June 12, 2025, as detailed in Exhibit 99.1.
When did Legend Biotech Corporation hold its 2025 Annual General Meeting of Shareholders?
Legend Biotech Corporation held its 2025 Annual General Meeting of Shareholders on June 12, 2025.
Where can the voting results of the 2025 Annual General Meeting be found?
The voting results are attached to the Form 6-K filing as Exhibit 99.1.
Which registration statements will incorporate this filing?
This Form 6-K filing, including Exhibit 99.1, will be incorporated by reference into the company's registration statements on Form F-3 (Nos. 333-257625, 333-272222 and 333-278050) and Form S-8 (No. 333-239478 and 333-283217).
What is the principal executive office address for Legend Biotech Corporation?
The principal executive office address for Legend Biotech Corporation is 2101 Cottontail Lane, Somerset, New Jersey 08873.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 12, 2025 regarding Legend Biotech Corp (LEGN).